RaySearch Laboratories AB (publ)

RaySearch Laboratories AB (publ)

RSLBF - Insider Information

Get informed when a big investor buys or sells

+ Follow
Market Cap$667.12M
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
RaySearch Laboratories AB (publ)RaySearch Laboratories AB (publ)29.82.23%25%0.51
$9.41

Current Fair Value

52.9% downside

Overvalued by 52.9% based on the discounted cash flow analysis.

Insider Trades

Loading insider trades…

Congress Trades

Loading congress trades…

Share Statistics

Market cap$667.12 Million
Enterprise Value$1.27 Billion
Annual dividend$0.43
Dividend yield2.23%
Earnings per Share$6.65
Beta0.93
Outstanding Shares33,356,185

Return

Return on Equity25.43%ROE
Return on Assets11.25%
Return on Invested Capital21.42%

Valuation & Multiples

P/E Ratio29.78P/E Ratio
PEG-256.93PEG
Price to Sales0.51Price to Sales
Price to Book Ratio0.83Price to Book Ratio
Enterprise Value to Revenue0.96
Enterprise Value to EBIT4.99
Enterprise Value to Net Income6
Total Debt to Enterprise0.6
Debt to Equity0.95Debt to Equity

Revenue Sources

No data

Last Earnings Call

Report Date
November 3, 2026
EPS
$0.19
Est. $0.24
Revenue
$39.20 M
Est. $37.74 M

Next Earnings Call

Expected Date
February 10, 2027
EPS Estimate
$0.28
Consensus analyst estimate
Revenue Estimate
$41.67 M
Consensus analyst estimate

Institutional Sentiment (Put/Call)

No data available for the latest quarter.

Institutional Ownership

No data available for the latest quarter.

About RaySearch Laboratories AB (publ)

464 employees
CEO: Johan Lof

RaySearch Laboratories AB (publ) is a global medical technology company dedicated to developing cutting-edge software solutions for cancer treatment. Its principal offering, RayStation, is a sophisticated treatment planning system that s...